Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:54 PM
Ignite Modification Date:
2025-12-24 @ 4:54 PM
NCT ID:
NCT00034450
Eligibility Criteria:
Inclusion:
* Patients with diagnosis of cancer and estimated life expectancy of less than 6 months.
* Patients who have undergone antineoplastic therapy which may worsen fatigue or promote carnitine deficiency will be eligible if completed the therapy more than 90 days prior to beginning the study.
Exclusion:
* Uncontrolled or severe cardiovascular, pulmonary, or renal disease.
* Patients with encephalopathy or psychiatric disorder sufficiently severe to impair completion of the questionnaire.
* Treatment or replacement therapy with any form of carnitine less than 12 months prior to enrollment.
* Known sensitivity to carnitine.
* History of seizures or stroke.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00034450
Study Brief:
Protocol Section:
NCT00034450